is mounjaro tirzepatide 2.5 mg / 0.5 ml Vial - Mounjaro (tirzepatide): Uses, Side Effects,

In phase 2 trial data published in The New England Journal of Medicine (2023), retatrutide demonstrated substantial weight loss in adults with obesity with some participants losing over 20% of their body weight over approximately 48 weeks

I am now back to the weight I was before I had kids

GLP-1 medications are eliminated through renal pathways, and reduced kidney function affects both drug tolerance and the risk of complications particularly dehydration-related acute kidney injury, which can occur when GI side effects (nausea, vomiting) reduce fluid intake

Halfway between knee and hip, on the outer front area where you can easily pinch a fold of skin